作者
Harshal Deshmukh, Emma G Wilmot, Robert Gregory, Dennis Barnes, Parth Narendran, Simon Saunders, Niall Furlong, Shafie Kamaruddin, Rumaisa Banatwalla, Roselle Herring, Anne Kilvert, Jane Patmore, Chris Walton, Robert EJ Ryder, Thozhukat Sathyapalan
发表日期
2020/9/1
期刊
Diabetes Care
卷号
43
期号
9
页码范围
2153-2160
出版商
American Diabetes Association
简介
OBJECTIVE
The FreeStyle Libre (FSL) flash glucose-monitoring device was made available on the UK National Health Service (NHS) drug tariff in 2017. This study aims to explore the UK real-world experience of FSL and the impact on glycemic control, hypoglycemia, diabetes-related distress, and hospital admissions.
RESEARCH DESIGN AND METHODS
Clinicians from 102 NHS hospitals in the UK submitted FSL user data, collected during routine clinical care, to a secure web-based tool held within the NHS N3 network. The t and Mann-Whitney U tests were used to compare the baseline and follow-up HbA1c and other baseline demographic characteristics. Linear regression analysis was used to identify predictors of change in HbA1c following the use of FSL. Within-person variations of HbA1c were calculated using.
RESULTS
Data were available for 10,370 FSL users (97% with type 1 diabetes), age 38.0 (±18 …
引用总数
20202021202220232024222504719